Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$324,157 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
14 quarters on record

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Derivatives in CGEM

reported options exposure · as of Jun 30, 2026
CallValue
$508,059
CallShares
27,900
PutValue
$668,307
PutShares
36,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in CGEM

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $668,307 36,700
2026-06-30 $508,059 27,900
2026-03-31 $324,157 22,812
2025-12-31 $119,025 11,500
2025-12-31 $1,933,835 186,844
2025-09-30 $1,784,247 300,885
2025-09-30 $85,392 14,400
2025-06-30 $368,087 48,883
2025-03-31 $260,377 34,396
2024-12-31 $1,091,328 89,600
2024-12-31 $177,620 14,583
2024-09-30 $8,187,534 489,100
2024-09-30 $354,134 21,155
2024-09-30 $1,499,904 89,600
2024-06-30 $1,684,633 96,596
2024-03-31 $357,907 21,004
2023-12-31 $140,641 13,802
2023-09-30 $150,356 16,614
2023-06-30 $579,781 53,883
2023-03-31 $221,858 21,687